OX40 agonist

OX40 agonist has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 28, 2026: “Drug pair eliminated breast cancer tumors in animals’ bones”.

Intervention

1 paper studies itUpdated

1 new paper in 30 daysSee all 1

  • Animals1

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 paper in 12 months
bioRxiv

Drug pair eliminated breast cancer tumors in animals’ bones

In animal experiments, blocking a signaling protein and stimulating immune cells also produced lasting immune memory when the animals faced cancer again.In animal experiments, blocking a signaling protein and stimulating immune cells also produced lasting immune memory when the animals faced cancer again.

Preprint: animal studyBreast cancer